| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Gerald James Benoit Jr. last filed a Form 4 in November 2023, as CEO at AIFF. Gerald James Benoit Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Gerald James Benoit Jr.'s trades have earned a below-average insider score of 33/100 across 26 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -74.5%.
At the last filing, the largest reported position was 1,985,781 shares of AIFF. Net of sales, the AIFF filings show accumulation of 619,136 shares.
Gerald James Benoit Jr. has 27 Form 4 filings on record from December 2021 to November 2023, all as CEO at Firefly Neuroscience (AIFF), 2021–2023.
The 111 reported transactions were 103 open-market purchases, 5 option or other derivative awards and 3 stock awards.
Counted by filing, the open-market trades come to 22 purchases worth about $585K and no sales.
The largest open-market purchase was 350,000 shares of AIFF at an average $0.50 on September 29, 2023, about $175K. Twelve months later AIFF was down 61%.
Shares as reported in the last Form 4 for each company; the most recent is from November 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 350,000 | $0.50 | $175,000.00 | +21.4% | -42.5% | -61.3% | |
| Dec 13, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 3,996 | $0.64 | $2,557.44 | +0.2% | +16.8% | -77.0% | |
| Dec 12, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 21,004 | $0.64 | $13,376.29 | +1.3% | +17.4% | -76.4% | |
| Dec 6, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 1,798 | $0.69 | $1,240.62 | +0.1% | +72.9% | -71.6% | |
| Dec 5, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 25,214 | $0.64 | $16,158.25 | +1.6% | +89.1% | -66.3% | |
| Dec 2, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 17,453 | $0.65 | $11,372.78 | +1.1% | +39.1% | -67.7% | |
| Dec 1, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 506 | $0.59 | $298.84 | - | +20.9% | -66.6% | |
| Nov 29, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 5,029 | $0.54 | $2,703.16 | +0.3% | +51.2% | -48.1% | |
| Oct 18, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 19,607 | $1.23 | $24,117.54 | +1.3% | -58.0% | -74.0% | |
| Oct 17, 2022 | AIFF Firefly Neuroscience, Inc. | CEO | Buy | 5,393 | $1.17 | $6,309.81 | +0.4% | -58.7% | -73.7% |